n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

Area of Science:

• Biochemistry
• Immunology
• Nutritional Science

Background:

• Inflammation is a key host defense mechanism against infection and injury.
• Dysregulated inflammation underlies numerous acute and chronic human diseases.
• Key inflammatory mediators include cytokines, eicosanoids, reactive oxygen species, and adhesion molecules.

Purpose of the Study:

• To evaluate the anti-inflammatory potential of long-chain omega-3 polyunsaturated fatty acids (PUFAs).
• To explore the mechanisms by which n-3 PUFAs modulate inflammatory pathways.
• To assess the clinical evidence for n-3 PUFA efficacy in inflammatory diseases.

Main Methods:

• Review of existing literature on n-3 PUFA metabolism and anti-inflammatory effects.
• Analysis of direct and indirect mechanisms of action, including eicosanoid substrate replacement and gene expression modulation.
• Evaluation of clinical trial data for various inflammatory conditions.

Main Results:

• High intakes of long-chain n-3 PUFAs reduce inflammatory eicosanoids, cytokines, reactive oxygen species, and adhesion molecules.
• n-3 PUFAs exert anti-inflammatory effects by altering eicosanoid substrate availability and gene transcription.
• n-3 PUFAs generate anti-inflammatory resolvins.
• Clinical evidence is strong for rheumatoid arthritis but weak for inflammatory bowel diseases and asthma.

Conclusions:

• Long-chain n-3 PUFAs are potent anti-inflammatory agents with therapeutic potential.
• Further large-scale, well-designed clinical trials are necessary to establish efficacy across diverse inflammatory diseases.
• The precursor alpha-linolenic acid does not show significant anti-inflammatory effects at typical intakes.